NURS 3301|ATI CAPSTONE PHARM 1, New One 2020 complete solution guide.
ATI CAPSTONE PHARM 1 (chapters 1-47) Chapter 14 – Assessing Prior to the Admin of Acetazolamide 1. Weigh daily 2. Monitor for postural hypotension 3. Increase fluid intake to 2 to 3 L/day, unless contraindicated. Chapter 14 – Evaluating Client Teaching about Brimonidine Ophthalmic Drops 1. Advise clients who wear soft contact lenses to administer brimonidine with lenses removed. 2. Delay insertion of the lens at least 15 min after administration to prevent absorption of medication into the lens 3. Advise clients to use caution with driving and other tasks Chapter 17 – Priority Adverse Effects of Inhaled Glucocorticoids 1. Client may experience oral Candidiasis 2. Bone loss can occur with inhaled and oral agents 3. Myopathy- as evidenced by muscle weakness Chapter 10 – Effects of Anticholinergic Medications 1. Client might experience dry mouth, blurred vision and photophobia 2. Other adverse effects include urinary retention 3. Constipation and tachycardia are anticholinergic effects Chapter 4 – Initiating an IV Catheter for an Older Adult 1. Avoid tourniquets. Use a blood pressure cuff to help visualize, but not overdistend, the veins to help prevent hematoma formation. 2. Instruct the client to hold his hand below the level of his heart to help distend and thus visualize the veins. 3. Avoid rigorous friction while cleaning the site. Chapter 7 – Teaching a client about Alprazolam 1. Advise clients to swallow sustained‑release tablets and to avoid chewing or crushing the tablets. 2. Inform clients about the possible development of dependency during and after treatment 3. Advise clients to take the medication as prescribed and to avoid abrupt discontinuation of treatment to prevent withdrawal manifestations Chapter 15 – Evaluating Client Understanding of Oxybutynin 1. The transdermal patch is administered two times per week. Instruct clients to apply to dry skin of the hip, abdomen, or buttock and to rotate sites. 2. Instruct clients that the shell of ER tablets will be eliminated whole in the stool. 3. Advise clients to swallow ER tablets whole and to avoid chewing or crushing the tablets. Chapter 17 – Adverse effects of Inhaled Ipratropium